Online GLP-1 Programs in North Dakota

Insurance

Does North Dakota Medicaid cover GLP-1s?

North Dakota Medicaid does not cover GLP-1s for weight loss (RX Index, 2026). Notably, North Dakota became the first state to require ACA individual and small-group commercial plans to cover weight-loss GLP-1s, effective January 2025, but that mandate does not extend to Medicaid, large-group, or grandfathered plans (Stateline, 2025). GLP-1s for type 2 diabetes are covered under Medicaid, as federal law requires.

Online Access

Getting a GLP-1 online in North Dakota

GLP-1s are not controlled substances, so North Dakota allows them to be prescribed via telehealth, but the clinician must establish a bona fide patient relationship through a real evaluation, not a questionnaire or audio-only contact alone, and must hold a North Dakota license. Online programs can serve residents statewide.

Compounding

Compounded semaglutide & tirzepatide in North Dakota

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). North Dakota adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in North Dakota

About 37% of North Dakota adults have obesity and roughly 11% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024). Demand centers on Fargo and Bismarck. North Dakota's first-in-the-nation commercial coverage mandate helps privately insured residents, but Medicaid enrollees seeking weight-loss GLP-1s still rely on cash-pay and telehealth.

Questions

North Dakota GLP-1 FAQ

Compound Guides

The GLP-1s behind these programs

Sources

How we sourced this page

Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.